Even if it is known that higher PDE5A expression may predict survival in human PCa in the clinical context (data from www.proteinatlas.org, accessed on accessed 30 March 2022), whether its functional inhibition may determine better survival in CRPC in humans is not known. This evidence concerns the gene PDE5A and posterior cortical atrophy.